Although the evidence to validate our findings is limited in MD patients, it has been shown in a case control study that 21% of patients with MD had elevated levels of pro-inflammatory cytokines such as IL-1β, IL-1RA, TNFα, and IL-6 in the supernatant from patient-derived peripheral blood mononuclear cells [23]. This evidence concerns the gene IL6 and Menkes disease.